Lactose (India) Ltd | 139 Cr. | 98.8 | 247/84.3 | 27.0 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 5.47 Cr. | 2.86 | 4.33/2.50 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 36.4 Cr. | 49.0 | 94.9/45.2 | | 8.73 | 0.00 % | 41.5 % | 14.4 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 33.7 Cr. | 23.0 | 29.1/13.1 | 33.0 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 67.2 Cr. | 89.2 | 155/79.0 | 15.3 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 51,327 Cr. | 1,819 | 1,879/1,275 | 38.9 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 298 Cr. | 13.1 | 29.0/11.2 | 18.5 | 8.21 | 0.00 % | 12.5 % | 9.03 % | 1.00 |
Ganga Pharmaceuticals Ltd | 6.44 Cr. | 13.3 | 27.1/9.25 | 80.5 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 393 Cr. | 832 | 904/635 | 18.9 | 299 | 0.08 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 103 Cr. | 20.7 | 32.0/14.6 | 35.1 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 1,048 Cr. | 356 | 449/194 | 13.7 | 123 | 0.35 % | 21.7 % | 23.4 % | 5.00 |
Fabino Enterprises Ltd | 5.61 Cr. | 26.7 | 39.0/22.8 | 43.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 12.1 Cr. | 4.85 | 10.4/2.11 | 134 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 320 Cr. | 330 | 477/112 | | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,182 Cr. | 1,191 | 1,584/1,070 | 54.6 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 180 Cr. | 0.97 | 1.37/0.53 | 24.0 | 1.12 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 58.8 Cr. | 24.4 | 26.3/6.40 | 60.6 | 16.0 | 0.00 % | 6.11 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 11.4 Cr. | 11.3 | 18.9/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 210 Cr. | 588 | 999/567 | 8.49 | 563 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 58.2 Cr. | 58.2 | 58.2/26.1 | 194 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 17.7 Cr. | 38.6 | 88.7/38.6 | 35.3 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 10.2 Cr. | 4.07 | 23.6/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 19.5 Cr. | 130 | 154/55.1 | 57.4 | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 16.8 Cr. | 30.7 | 30.7/6.08 | 560 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 43.7 Cr. | 58.0 | 85.5/46.2 | 50.8 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 5.28 Cr. | 17.6 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 15,817 Cr. | 912 | 986/401 | 51.8 | 65.3 | 0.11 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 103 Cr. | 23.8 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.2 Cr. | 22.1 | 46.0/17.4 | 19.3 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 153 Cr. | 265 | 418/241 | 16.5 | 119 | 1.70 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 21.1 Cr. | 35.8 | 62.6/14.8 | 52.7 | 43.2 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 66,876 Cr. | 1,141 | 1,593/994 | 19.2 | 557 | 0.39 % | 14.3 % | 11.2 % | 1.00 |
Auro Laboratories Ltd | 163 Cr. | 261 | 300/156 | 88.5 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 1,064 Cr. | 212 | 250/148 | 22.5 | 65.1 | 0.59 % | 19.5 % | 15.3 % | 5.00 |
ANG Lifesciences India Ltd | 44.3 Cr. | 33.9 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Ami Organics Ltd | 9,630 Cr. | 1,176 | 1,322/504 | 60.7 | 160 | 0.13 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 5.29 Cr. | 0.80 | 1.45/0.62 | 529 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 279 Cr. | 36.4 | 77.7/34.1 | 32.3 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 10.1 Cr. | 17.2 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 91.6 Cr. | 3.89 | 6.25/2.82 | 167 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 72,793 Cr. | 34,256 | 37,000/25,260 | 51.5 | 1,992 | 1.39 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 8,253 Cr. | 911 | 950/521 | 30.3 | 220 | 0.34 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 201 Cr. | 70.9 | 75.8/31.3 | 50.0 | 48.8 | 0.00 % | 6.00 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 3,579 Cr. | 1,216 | 1,299/535 | | 78.1 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 28,092 Cr. | 1,729 | 1,870/750 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 888 Cr. | 271 | 330/154 | 29.1 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 635 Cr. | 475 | 492/270 | 16.3 | 420 | 0.00 % | 11.4 % | 7.45 % | 10.0 |
Unichem Laboratories Ltd | 4,253 Cr. | 604 | 950/512 | 31.1 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,851 Cr. | 1,310 | 1,923/991 | 26.0 | 754 | 0.77 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,12,795 Cr. | 3,333 | 3,591/2,870 | 58.9 | 224 | 0.95 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,147 Cr. | 125 | 317/115 | 38.5 | 43.7 | 0.40 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,796 Cr. | 19.1 | 27.9/13.2 | 36.8 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,473 Cr. | 1,079 | 1,360/597 | 98.5 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 5,696 Cr. | 261 | 281/102 | | 5.04 | 0.00 % | 84.4 % | 84.6 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,97,834 Cr. | 1,658 | 1,960/1,550 | 34.7 | 301 | 0.96 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,827 Cr. | 634 | 886/441 | 5,235 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,113 Cr. | 238 | 398/175 | 30.9 | 75.9 | 0.17 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 366 Cr. | 1,211 | 1,750/765 | 19.6 | 650 | 0.12 % | 11.8 % | 10.0 % | 10.0 |
Shilpa Medicare Ltd | 8,449 Cr. | 864 | 1,003/530 | 94.4 | 243 | 0.00 % | 7.94 % | 4.28 % | 1.00 |
Sequent Scientific Ltd | 4,637 Cr. | 185 | 241/111 | 209 | 28.1 | 0.00 % | 8.97 % | 3.25 % | 2.00 |
Sanofi India Ltd | 13,798 Cr. | 5,991 | 7,600/4,146 | 36.3 | 374 | 1.95 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 4,192 Cr. | 2,534 | 2,977/1,540 | 36.3 | 321 | 0.79 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 9,427 Cr. | 5,679 | 6,176/4,863 | 36.2 | 323 | 1.41 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 204 Cr. | 57.7 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 25,794 Cr. | 5,638 | 6,453/3,701 | 40.2 | 922 | 0.62 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 118 Cr. | 95.8 | 348/81.0 | 8.82 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,542 Cr. | 415 | 582/130 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,695 Cr. | 728 | 1,998/604 | 37.1 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 15,396 Cr. | 12,000 | 18,100/7,855 | 73.9 | 1,188 | 0.10 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 374 Cr. | 16.7 | 56.5/15.5 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 18,260 Cr. | 1,020 | 1,639/660 | 9.70 | 425 | 0.93 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 3,482 Cr. | 63.5 | 101/41.7 | 29.5 | 21.1 | 0.00 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 11,780 Cr. | 260 | 359/168 | 31.0 | 54.4 | 0.23 % | 20.1 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 147 Cr. | 93.0 | 145/65.5 | 21.3 | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 395 Cr. | 111 | 177/90.2 | 49.8 | 29.0 | 0.00 % | 9.93 % | 9.24 % | 10.0 |
Lupin Ltd | 87,690 Cr. | 1,920 | 2,403/1,766 | 26.7 | 377 | 0.42 % | 21.5 % | 20.8 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,129 Cr. | 564 | 980/499 | 13.7 | 335 | 0.32 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 42,901 Cr. | 795 | 798/390 | 126 | 84.6 | 0.15 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,202 Cr. | 1,158 | 1,235/483 | 30.1 | 256 | 0.00 % | 18.3 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 180 Cr. | 83.6 | 129/63.6 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 868 Cr. | 180 | 370/155 | 22.5 | 107 | 1.67 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 698 Cr. | 434 | 500/271 | 28.0 | 126 | 0.00 % | 17.3 % | 13.2 % | 10.0 |
Jubilant Pharmova Ltd | 18,303 Cr. | 1,149 | 1,310/701 | 33.0 | 393 | 0.44 % | 9.54 % | 9.50 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,478 Cr. | 1,633 | 2,030/1,303 | 38.6 | 221 | 0.75 % | 26.6 % | 20.8 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,470 Cr. | 221 | 328/132 | 37.0 | 36.1 | 0.91 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 36,927 Cr. | 1,456 | 1,758/1,168 | 42.6 | 274 | 0.27 % | 15.0 % | 13.1 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,671 Cr. | 91.0 | 108/57.5 | 26.4 | 57.5 | 1.10 % | 8.85 % | 6.12 % | 2.00 |
Ind-Swift Ltd | 92.1 Cr. | 17.0 | 34.7/12.0 | 11.8 | 74.3 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 708 Cr. | 117 | 186/67.2 | 8.55 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 3,070 Cr. | 333 | 388/190 | | 111 | 0.45 % | 0.48 % | 7.00 % | 2.00 |
Hikal Ltd | 4,227 Cr. | 343 | 465/309 | 46.6 | 102 | 0.35 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,542 Cr. | 1,813 | 3,379/1,243 | 56.1 | 369 | 0.33 % | 9.62 % | 9.07 % | 10.0 |
Gufic BioSciences Ltd | 3,459 Cr. | 345 | 504/285 | 49.5 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 11,636 Cr. | 480 | 725/412 | 24.3 | 153 | 0.31 % | 15.1 % | 13.8 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 51,327 Cr. | 1,819 | 1,879/1,275 | 38.9 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 56,056 Cr. | 3,309 | 3,516/1,921 | 64.1 | 115 | 1.27 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 30,935 Cr. | 1,878 | 2,221/1,200 | 28.4 | 592 | 1.07 % | 15.9 % | 11.6 % | 1.00 |
FDC Ltd | 8,227 Cr. | 505 | 659/359 | 30.8 | 140 | 0.99 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 23,578 Cr. | 1,731 | 1,910/987 | 67.3 | 210 | 0.42 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,04,786 Cr. | 1,256 | 1,421/1,020 | 18.8 | 402 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,988 Cr. | 254 | 308/155 | | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,18,406 Cr. | 1,466 | 1,702/1,310 | 23.0 | 386 | 0.88 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,447 Cr. | 2,032 | 2,641/1,422 | 28.8 | 375 | 0.25 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 428 Cr. | 145 | 203/82.0 | | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,612 Cr. | 153 | 186/105 | 19.1 | 99.7 | 0.32 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 77.7 Cr. | 47.8 | 92.0/40.4 | 139 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 49,822 Cr. | 373 | 405/291 | 51.8 | 180 | 0.13 % | 6.13 % | 4.64 % | 5.00 |
Beta Drugs Ltd | 1,777 Cr. | 1,760 | 2,215/1,134 | 38.8 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 161 Cr. | 101 | 158/76.3 | 22.3 | 48.6 | 1.18 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 203 Cr. | 85.9 | 95.0/67.8 | 32.2 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 22,858 Cr. | 9,143 | 10,691/6,220 | 131 | 308 | 0.26 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,063 Cr. | 713 | 863/544 | 40.6 | 113 | 0.64 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 218 Cr. | 104 | 145/82.2 | 11.1 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 56,581 Cr. | 4,733 | 6,440/4,492 | 26.1 | 1,002 | 0.85 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 19,192 Cr. | 977 | 1,304/725 | 33.8 | 264 | 1.13 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 516 Cr. | 903 | 1,754/763 | 30.3 | 688 | 0.55 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 32,392 Cr. | 2,591 | 3,486/2,022 | 35.4 | 303 | 1.39 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,720 Cr. | 333 | 571/258 | 28.4 | 127 | 1.56 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,386 Cr. | 477 | 635/312 | 27.9 | 136 | 0.21 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,792.38 Cr | 1,191.94 | | 105.97 | 194.39 | 0.30% | 16.63% | 15.26% | 6.18 |